Skip to content

Company information lookup

MESOBLAST LIMITED (MSB)

A biotechnology company in the area of adult stem cell technology.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
MSB 4.850 0.62% 4.820 4.850 4.890 4.910 4.800 249,671

MESOBLAST LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code MSB
Securities
Official Listing Date 16 December, 2004
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.mesoblast.com
Registered Office Address Level 39, 55 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (03) 9639 6036
Head Office Fax (03) 9639 6030
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Brian Jamieson (Non Exec. Chairman, Non Exec. Director)
Mr Donal O'Dwyer (Deputy Chairman, Non Exec. Director)
Prof. Silviu Itescu (Managing Director, CEO)
Dr Eric A Rose (Non Exec. Director)
Mr Michael Spooner (Non Exec. Director)
Dr Ben - Zion Weiner (Non Exec. Director)
Mrs Jenni Pilcher (CFO)
Company Secretary Mrs Jenni Pilcher
Principal Activities A biotechnology company in the area of adult stem cell technology.

MESOBLAST LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
08/04/2014 asterix Response to ASX price query 5 PDF
27/03/2014   Keynote Presentation to Alliance for Regenerative Medicine 18 PDF
12/03/2014   Initial Director's Interest Notice 2 PDF
11/03/2014   Key Pharmaceutical Executive Joins Mesoblast 1 PDF
06/03/2014   Director Appointment/Resignation 1 PDF
26/02/2014   2014 Half-Year Financial Results & Corporate Strategy 27 PDF
26/02/2014   Mesoblast Reports Strong Half-Year Financial Results 2 PDF
26/02/2014 asterix Half Yearly Report and Accounts 30 PDF
20/02/2014 asterix Key European Patent Granted for Mesoblast's MPCs 2 PDF
03/02/2014   Boardroom Radio Interview with Mesoblast Chief Executive 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 4.850 0.62% 4.910 4.800 249,671
16 Apr 2014 4.820 0.21% 4.910 4.760 405,574
15 Apr 2014 4.810 1.48% 4.875 4.790 387,387
14 Apr 2014 4.740 -3.46% 4.900 4.730 387,632
11 Apr 2014 4.910 -2% 4.950 4.780 383,531

* Volume of shares shown represents only those shares traded on ASX.

MESOBLAST LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security MSB. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security MSB

Warrants & Structured Products

Warrants & Structured Products are available over the security MSB. Click here to view the current warrant issue details.

ASX CFDs

No Contracts For Differences are available over the security MSB